VAX-ID®

Product Description

VAX-ID®  is an award-winning patented drug delivery device suited for reliable intradermal injection with high ease of use. The devices are suited for all ages and populations. The intended users are healthcare providers.Devices are currently available for investigational use only (IUO) and research use only (RUO). CE marking and FDA approval are expected early 2025

Idevax

  • Country/Region:
    Belgium
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Medical Devices
Specifications
  • Details
    VAX-ID® can be preconfigured with a 32G, 30G, or 27G needle with a predefined penetration depth of less than 1mm allowing for reliable drug delivery in the dermal layer of the skin. The devices are suited for delivery of small volumes of medicinal substances (typically 0.05cc – 0.2cc per injection).
  • Selling Points
    Convenience; Immune Health; Developed by a multidisciplinary team, VAX-ID® allows for
    - Accurate injection at a predefined penetration depth- Dose sparing opportunities
    - Activation protection and needle-stick injury prevention
    - Low in pain and no needle phobia
    - Easy to use, potentially leading to self-administration
    - User independent

Idevax

  • Country/Region:
    Belgium
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Medical Devices

Idevax resources (1)

  • Video How VAX-ID works

    The video shows how VAX-ID, a skin drug delivery device for reliable injection in the dermal layer of the skin, works.